Pulse.

a daily field guide to health research that matters

◆ Console

‹ Mon · 16 Nov 2026
Standard addition

Sodium-glucose cotransporter-2 inhibitor therapy and risk of mortality and morbidity following hospitalization for pneumonia in type 2 diabetes mellitus: An international propensity score-matched cohort study.

Diabetes patients taking SGLT2 inhibitors had lower risks of death and complications after pneumonia hospitalization, contrary to earlier safety concerns.

This PubMed record examines Sodium-glucose cotransporter-2 inhibitor therapy and risk of mortality and morbidity following hospitalization for pneumonia in type 2 diabetes mellitus: An international propensity score-matched cohort study. It reports CONCLUSION: Patients with T2DM who used SGLT2 inhibitors had significantly lower risks of mortality and morbidity following hospitalization for pneumonia, including a notable reduction in DKA, contrary to prior concerns.

What the study was

Study design
Randomized controlled trial
Population
Human participants
Category
Public Health
Maturity
Validated
Journal
Sage open chronic disease

Why it surfaced

Randomized controlled trial; conservative rapid-triage score based on PubMed title, publication type, and abstract.

A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.